Tegillarca granosa extract Haishengsu inhibits tumor activity via a mitochondrial‑mediated apoptotic pathway

Chen,Xue‑Hong; Han,Yan‑Tao; Ye,Jun‑Li; Chang,Zhi‑Shang; Wang,Chun‑Bo; Chen,Shou‑Guo

doi:10.3892/mmr.2018.8654

Tegillarca granosa extract Haishengsu inhibits tumor activity via a mitochondrial‑mediated apoptotic pathway

Authors:
- Xue‑Hong Chen
- Yan‑Tao Han
- Jun‑Li Ye
- Zhi‑Shang Chang
- Chun‑Bo Wang
- Shou‑Guo Chen
View Affiliations

Affiliations: Department of Pharmacology, Basic Medical College, Qingdao University, Qingdao, Shandong 266071, P.R. China, Department of Technology, Qingdao Haihui Biochemical Pharmaceutical Company, Qingdao, Shandong 266031, P.R. China
Published online on: March 1, 2018 https://doi.org/10.3892/mmr.2018.8654
Pages: 6828-6834

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Haishengsu (HSS) is an active natural extract isolated from Tegillarca granosa, which has previously been demonstrated to inhibit the proliferation of several types of cancer cells in vitro. Our previous study indicated that HSS may induce apoptosis to suppress growth of human hepatocellular carcinoma BEL‑7402 cells by activating Fas pathway. The present study demonstrated that HSS treatment induces the in vitro apoptosis of BEL‑7402 cells via the mitochondrial‑mediated apoptotic pathway detected by DNA fragmentation assay, caspase activity assay and transmission electron microscopy assay, and inhibits tumor xenograft growth in vivo. Alterations in apoptotic regulatory proteins were detected, including decreased expression of B‑cell lymphoma2 (Bcl‑2), upregulation of Bcl‑2‑associated X protein and mitochondrial cytochrome c release, and downstream activation of apoptotic signaling. Furthermore, apoptotic induction was caspase‑dependent, as indicated by cleavage of the caspase substrate, poly (ADP‑ribose) polymerase. Oral administration of 62.5‑250 mg/kg HSS markedly educed the growth of hepatocellular carcinoma tumor xenografts in nude mice. In addition, immunohistochemical staining for caspase‑3 protein and transmission electron microscopy further indicated the induction of apoptosis in these tumor tissues. Taken together, the present study demonstrated that HSS may effectively induce apoptosis to suppress the growth of BEL‑7402 cells in vitro and in vivo, and therefore may hold promise for further development as a novel cancer therapy.

View Figures

View References

1	Burgess JG: New and emerging analytical techniques for marine biotechnology. Curr Opin Biotechnol. 23:29–33. 2012. View Article : Google Scholar : PubMed/NCBI
2	Lin X, Liu M, Hu C and Liao DJ: Targeting cellular proapoptotic molecules for developing anticancer agents from marine sources. Curr Drug Targets. 11:708–715. 2010. View Article : Google Scholar : PubMed/NCBI
3	Abraham I, El Sayed K, Chen ZS and Guo H: Current status on marine products with reversal effect on cancer multidrug resistance. Mar Drugs. 10:2312–2321. 2012. View Article : Google Scholar : PubMed/NCBI
4	Gupta SC, Kim JH, Prasad S and Aggarwal BB: Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev. 29:405–434. 2010. View Article : Google Scholar : PubMed/NCBI
5	Leal MC, Madeira C, Brandão CA, Puga J and Calado R: Bioprospecting of marine invertebrates for new natural products-a chemical and zoogeographical perspective. Molecules. 17:9842–9854. 2012. View Article : Google Scholar : PubMed/NCBI
6	Hu GP, Yuan J, Sun L, She ZG, Wu JH, Lan XJ, Zhu X, Lin YC and Chen SP: Statistical research on marine natural products based on data obtained between 1985 and 2008. Mar Drugs. 9:514–525. 2011. View Article : Google Scholar : PubMed/NCBI
7	Li GY, Yu XM, Zhang HW, Zhang B, Wang CB, Xin YC, Yang CZ, Zhou RX and Wang LX: Haishengsu as an adjunct therapy to conventional chemotherapy in patients with non-small cell lung cancer: A pilot randomized and placebo-controlled clinical trial. Complement Ther Med. 17:51–55. 2009. View Article : Google Scholar : PubMed/NCBI
8	Liu JZ, Chen SG, Zhang B, Wang CB, Zhao XW, Li GY and Wang LX: Effect of haishengsu as an adjunct therapy for patients with advanced renal cell cancer: A randomized and placebo-controlled clinical trial. J Altern Complement Med. 15:1127–1130. 2009. View Article : Google Scholar : PubMed/NCBI
9	Gao MQ, Han YT, Zhu L, Chen SG, Hong ZY and Wang CB: Cytotoxicity of natural extract from Tegillarca granosa on ovarian cancer cells is mediated by multiple molecules. Clin Invest Med. 32:E368–E375. 2009. View Article : Google Scholar : PubMed/NCBI
10	Liu HP, Gao ZH, Cui SX, Xue X, Hou CY, Jiang ZM, Zhao CR, Wang CB, Chen SG and Qu XJ: Haishengsu, a protein from shellfish Tegillarca L. granosa, inhibits the growth and the activity of matrix metalloproteinases-2 and −9 in human lung carcinoma. Food Biophysics. 6:390–396. 2011. View Article : Google Scholar
11	Li GY, Liu JZ, Zhang B, Yang M, Chen SG, Hou M and Wang LX: Tegillarca granosa extract Haishengsu (HSS) suppresses expression of mdr1, BCR/ABL and sorcin in drug-resistant K562/ADM tumors in mice. Adv Med Sci. 58:112–117. 2013. View Article : Google Scholar : PubMed/NCBI
12	Li GY, Liu JZ, Chen SG, Zhang B, Wang CB and Wang LX: Tegillarca granosa extract Haishengsu inhibits the expression of p-glycoprotein and induces apoptosis in drug-resistant K562/ADM cells. Pharm Biol. 48:529–533. 2010. View Article : Google Scholar : PubMed/NCBI
13	Xu W, Kong X, Jiang C, Liu X and Xu L: The anti-tumor effect of a polypeptide extracted from Tegillarca granosa Linnaeus on renal metastatic tumor OS-RC-2 cells. Arch Med Sci. 11:849–855. 2015. View Article : Google Scholar : PubMed/NCBI
14	Li GY, Liu JZ, Chen SG, Wang CB, Bin Z and Wang LX: Effect of a seashell protein Haishengsu on the immunological function of mice with Ehrlich ascites tumor. Immunopharmacol Immunotoxicol. 31:669–674. 2009. View Article : Google Scholar : PubMed/NCBI
15	Chen X, Han Y, Zhan S, Wang C and Chen S: Tegillarca granosa extract Haishengsu induces apoptosis in human hepatocellular carcinoma cell line BEL-7402 via Fas-signaling pathways. Cell Biochem Biophys. 71:837–844. 2015. View Article : Google Scholar : PubMed/NCBI
16	Hajra KM and Liu JR: Apoptosome dysfunction in human cancer. Apoptosis. 9:691–704. 2004. View Article : Google Scholar : PubMed/NCBI
17	Fesik SW: Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 5:876–885. 2005. View Article : Google Scholar : PubMed/NCBI
18	Khodarev NN, Sokolova IA and Vaughan ATM: Mechanisms of induction of apoptotic DNA fragmentation. Int J Radiat Biol. 73:455–467. 1998. View Article : Google Scholar : PubMed/NCBI
19	Han YT, Chen XH, Gao H, Ye JL and Wang CB: Physcion inhibits the metastatic potential of human colorectal cancer SW620 cells in vitro by suppressing the transcription factor SOX2. Acta pharmacol Sin. 37:264–275. 2016. View Article : Google Scholar : PubMed/NCBI
20	Ola MS, Nawaz M and Ahsan H: Role of Bcl-2 family proteins and caspases in the regulation of apoptosis. Mol Cell Biochem. 351:41–58. 2011. View Article : Google Scholar : PubMed/NCBI
21	Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG and Earnshaw WC: Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ice. Nature. 371:346–347. 1994. View Article : Google Scholar : PubMed/NCBI
22	Alves RC, Alves D, Guz B, Matos C, Viana M, Harriz M, Terrabuio D, Kondo M, Gampel O and Polletti P: Advanced hepatocellular carcinoma. Review of targeted molecular drugs. Ann Hepatol. 10:21–27. 2011.PubMed/NCBI
23	Jemal A, Bray F, Center MM, Ferlay J, Ward E and Forman D: Global cancer statistics. CA Cancer J Clin. 61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
24	Bruix J and Sherman M: American Association for the Study of Liver Diseases: Management of hepatocellular carcinoma: An update. Hepatology. 53:1020–1022. 2011. View Article : Google Scholar : PubMed/NCBI
25	Newman DJ, Cragg GM and Snader KM: Natural products as sources of new drugs over the period 1981–2002. J Nat Prod. 66:1022–1037. 2003. View Article : Google Scholar : PubMed/NCBI
26	Indran IR, Tufo G, Pervaiz S and Brenner C: Recent advances in apoptosis, mitochondria and drug resistance in cancer cells. Biochim Biophys Acta. 1807:735–745. 2011. View Article : Google Scholar : PubMed/NCBI
27	Dai JJ, Niu YF, Wu CF, Zhang SH and Zhang DF: Both death receptor and mitochondria mediated apoptotic pathways participated the occurrence of apoptosis in porcine vitrified mii stage oocytes. Cryo Letters. 37:129–136. 2016.PubMed/NCBI
28	Yoo KH, Park JH, Lee DK, Fu YY, Baek NI and Chung IS: Pomolic acid induces apoptosis in SK-OV-3 human ovarian adenocarcinoma cells through the mitochondrial-mediated intrinsic and death receptor-induced extrinsic pathways. Oncol Lett. 5:386–390. 2013. View Article : Google Scholar : PubMed/NCBI
29	Qi F, Li A, Inagaki Y, Xu H, Wang D, Cui X, Zhang L, Kokudo N, Du G and Tang W: Induction of apoptosis by cinobufacini preparation through mitochondria- and Fas-mediated caspase-dependent pathways in human hepatocellular carcinoma cells. Food Chem Toxicol. 50:295–302. 2012. View Article : Google Scholar : PubMed/NCBI
30	Elumalai P, Gunadharini DN, Senthilkumar K, Banudevi S, Arunkumar R, Benson CS, Sharmila G and Arunakaran J: Induction of apoptosis in human breast cancer cells by nimbolide through extrinsic and intrinsic pathway. Toxicol Lett. 215:131–142. 2012. View Article : Google Scholar : PubMed/NCBI
31	Li P, Tian W and Ma X: Alpha-mangostin inhibits intracellular fatty acid synthase and induces apoptosis in breast cancer cells. Mol Cancer. 13:1382014. View Article : Google Scholar : PubMed/NCBI